Biotech player Brain gets boost from investor

By Simon Pitman

- Last updated on GMT

Biotech player Brain gets boost from investor

Related tags Carbon dioxide

Germany-based biotech ingredient player Brain has received a boost to its longer-term expansion goals thanks to support from a new investor.

DAH Beteiligungs has subscribed to a total of 1,641,434 new-registered no-par-value shares, which corresponds to a 10% share of the company’s total capital.

As part of Brain’s future expansion plans, company executives say that the boost to its funds will help to fund a new acquisition that will give the company scope for further expansion in the future.

One of Brain’s primary focuses is the cosmetics and personal care arena, for which it develops natural-based bioactive ingredients that mainly target the skin care category.

Investing in sustainability

The company is also aiming to make its business model more sustainable by investing in production processes that are both more efficient and better for the environment.

“The aim is to reduce the dependency on valuable, limited raw materials in favour of more sustainability, nature and climate protection,”​ said Dr Juergen Eck, CEO of Brain.

“Examples of this are our DOLCE program for the reduction of sugar consumption, our BioXtractor system for the extraction of precious metals from waste streams, or the use of the greenhouse gas carbon dioxide as a raw material.“

More biotech products planned

The investment by Beteiligungs’ capital comes 18 months after the company’s initial IPO and will increase the company’s share capital from Euros 16.4 million to Euros 18 million.

“Brain has been pursuing a successful growth strategy for several years,”​ said Frank Goebel, CFO of Brain.

“The goal is, in addition to intensifying research collaborations with industrial partners, to develop and market our own biotechnological product candidates. In line with this strategy, the proceeds from the capital increase shall primarily be used to finance small and medium-sized acquisitions. Consequently, also our shareholders will benefit from our sustainable corporate strategy.”

Related topics Formulation & Science Skin Care

Related news

Related products

show more

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

How Nutricosmetics Can Enhance Skin Beauty

How Nutricosmetics Can Enhance Skin Beauty

Content provided by Activ'Inside | 11-Dec-2023 | White Paper

In the ever-evolving realm of nutricosmetics, where inner wellness meets outer beauty, few natural ingredients have captured the spotlight quite like grapes.

Ultimate Antimicrobial Solution for BPC

Ultimate Antimicrobial Solution for BPC

Content provided by Acme-Hardesty Company | 11-Oct-2023 | White Paper

Sharomix™ EG10, a versatile broad-spectrum antimicrobial liquid blend for preserving personal care products, ensures safety at usage levels ranging from...

Acme-Hardesty Expands Product Line into Canada

Acme-Hardesty Expands Product Line into Canada

Content provided by Acme-Hardesty Company | 07-Jul-2023 | Product Brochure

Acme-Hardesty’s latest expansion into Canada includes Resplanta®, Botaneco®, and BYK from our partners Sharon Personal Care and Eckart Effect Pigments...

Related suppliers